跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
莱得怡 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Amoxicillin and Clavulanate Potassium Tablets
Approved
化学药品
Amoxicillin and Clavulanate Potassium Tablets
Sandoz Gmbh
🇨🇳 National Medical Products Administration
Approval Date
May 28, 2020
Approval ID
7MazXbZVUJd
Company
Sandoz Gmbh
Type
化学药品
Approval Details
Approval Id
7MazXbZVUJd
Approval Number
H20150630
Generic Name
阿莫西林克拉维酸钾片
Generic Name En
Amoxicillin and Clavulanate Potassium Tablets
Trade Name
莱得怡
Brand Name
莱得怡
Drug Type
化学药品
Dosage Form
片剂
Strength
1.0g（C₁₆H₁₉N₃O₅S 0.875g与C₈H₉NO₅ 0.125g）
Reg Date
2020-05-28
Expired Date
2025-05-27
Company Name
Sandoz Gmbh
Company Address
Biochemiestraβe 10, AT-6250 Kundl, Austria
Production Company Name
Sandoz Gmbh
Production Company Address
Biochemiestraβe 10, AT-6250 Kundl, Austria
Company Detail Path
/organization/sandoz-gmbh
Production Company Detail Path
/organization/sandoz-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 28, 2020
Approval ID
7MazXbZVUJd
Type
化学药品
Back to NMPA Approvals
